CD4 and head and neck squamous cell carcinoma: Recently, the prognostic value of various tumor-infiltrating CD4+ T-cell populations (CD4+CD25+, CD4+CD69+, and CD4+FOXP3+ T cells) was determined in HNSCC patients [114].